Evidence map›Paper›PMID 28155585›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

Dabigatran ameliorates post-haemorrhagic hydrocephalus development after germinal matrix haemorrhage in neonatal rat pups.

Damon Klebe, Jerry J Flores, Devin W McBride, Paul R Krafft, William B Rolland, Tim Lekic, John H Zhang

Expression of concernOpen access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Recovery of the brain after intraventricular hemorrhage.Seminars in fetal & neonatal medicine · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Damon Klebe1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Jerry J Flores1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Devin W McBride1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Paul R Krafft1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
William B Rolland1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Tim Lekic1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
John H Zhang1 Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Loma Linda University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aim to determine if direct thrombin inhibition by dabigatran will improve long-term brain morphological and neurofunctional outcomes and if potential therapeutic effects are dependent upon reduced PAR-1 stimulation and consequent mTOR activation. Germinal matrix haemorrhage was induced by stereotaxically injecting 0.3 U type VII-S collagenase into the germinal matrix of P7 rat pups. Animals were divided into five groups: sham, vehicle (5% DMSO), dabigatran intraperitoneal, dabigatran intraperitoneal + TFLLR-NH

Indexed as

Administration, IntranasalAnimalsAnimals, NewbornAntithrombinsDabigatranDisease Models, AnimalExtracellular MatrixHydrocephalusInjections, IntraperitonealIntracranial HemorrhagesMaze LearningOligopeptidesPlatelet Aggregation InhibitorsPyrrolesQuinazolinesReceptor, PAR-1AntithrombinsDabigatranN3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamineOligopeptidesPAR-1-activating peptidePlatelet Aggregation InhibitorsPyrrolesQuinazolinesReceptor, PAR-1Germinal matrix haemorrhagemammalian target of rapamycinpost-haemorrhagic hydrocephaluspost-haemorrhagic ventricular dilatationproteinase-activated receptors

Identifiers

PMID28155585
PMCPMC5584693
OpenAlexW2591631253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.